Which feature best distinguishes the immunisation schedule for Rotavirus vaccine from that of Oral Polio Vaccine (OPV) according to IAP recommendations?

Explanation

## Distinguishing Features of Rotavirus vs OPV Immunisation ### Key Distinguishing Feature: Contraindication Profile **High-Yield:** The best distinguishing feature between Rotavirus vaccine and OPV is that **Rotavirus vaccine is contraindicated in infants with a prior history of intussusception**, whereas OPV carries no such contraindication. This is a clinically significant and pharmacologically specific distinction. The early Rotavirus vaccine (RotaShield) was withdrawn from the US market in 1999 due to an increased risk of intussusception. Current vaccines (Rotarix, RotaTeq, Rotavac, Rotasiil) carry a small but recognized risk, and a **prior history of intussusception is an absolute contraindication** per IAP and WHO guidelines. ### Why Other Options Are Incorrect | Option | Assessment | |--------|------------| | **A) Rotavirus only in first year; OPV beyond 5 years** | Partially true but imprecise. Rotavirus is restricted to infants ≤8 months (last dose), not "first year" broadly. More importantly, this is a scheduling nuance, not the *best* distinguishing feature. | | **B) Rotavirus 3 doses 4 weeks apart; OPV at fixed milestones** | Factually inaccurate. Both vaccines follow milestone-based schedules (6, 10, 14 weeks per IAP 2023). The spacing distinction described is incorrect. | | **C) Rotavirus contraindicated in intussusception history; OPV has no such contraindication** | ✅ **Correct.** This is a unique, clinically important, and pharmacologically grounded distinction. | | **D) Rotavirus as liquid suspension; OPV as oral drops** | Both are oral formulations; this is not a meaningful distinguishing feature and is easily eliminated. | ### Comparison Table | Feature | Rotavirus | OPV | |---------|-----------|-----| | **Route** | Oral | Oral | | **Primary doses** | 3 (6, 10, 14 weeks) | 3 + birth dose | | **Boosters** | None | Yes (18–24 months, 4–6 years) | | **Age restriction** | Last dose ≤8 months | Birth through school age | | **Intussusception contraindication** | **Yes (absolute)** | No | **Clinical Pearl:** Per IAP 2023 and WHO position papers, a history of intussusception is an absolute contraindication to Rotavirus vaccination. This is unique among the oral vaccines in the childhood immunisation schedule and represents the most clinically meaningful distinguishing feature between Rotavirus vaccine and OPV. **Key Point:** When a question asks for the "best distinguishing feature," look for the option that is both factually accurate AND clinically unique — the intussusception contraindication satisfies both criteria. [cite: IAP Immunisation Schedule 2023; WHO Position Paper on Rotavirus Vaccines, 2013; KD Tripathi Essentials of Medical Pharmacology, 8th ed.]